163 results on '"Umpierrez, Guillermo"'
Search Results
2. 140-LB: Management of Inpatient Hyperglycemia Guided by Continuous Glucose Monitoring (CGM) in Insulin-Treated Patients with Diabetes—A Randomized Clinical Trial
3. 22-OR: Finerenone in Patients across the Spectrum of CKD and T2D by GLP-1RA Use
4. 1323-P: Insulin Secretion at Diabetes Remission in Obese Blacks Presenting with Diabetic Ketoacidosis
5. 124-OR: HbA1c Variability Is Independently Associated with Lower-Extremity Amputation and Death among Patients with Diabetic Foot Ulcers
6. 805-P: Sarcopenia in Insulin-Treated Older Adult Patients with Type 2 Diabetes
7. 729-P: Relationship between Body Weight Change and Glycemic Control with Tirzepatide Treatment in People with Type 2 Diabetes
8. 697-P: Inpatient Glycemic Control and Glucose Variability by Continuous Glucose Monitoring in Older Adults with Type 2 Diabetes
9. 919-P: Trends in Glycemic Control during the COVID-Pandemic in a Large Academic Health Care System
10. 27-LB: Prevalence and Severity of Diabetic Retinopathy in African Americans with End-Stage Kidney Disease
11. 847-P: Assessment of Intestinal Microbiota in African-Americans Diabetics Thriving on or Not Tolerating This Drug
12. 704-P: Time in Range and Time Below Range in Insulin-Treated Older Adults with Type 2 Diabetes
13. 217-OR: A Randomized Controlled Trial Comparing the Safety and Efficacy of IDegLira vs. Basal Bolus in Patients with Poorly Controlled Type 2 Diabetes and Very High HbA1c (>9%–15%) : IDegLira HIGH Trial
14. 828-P: Inpatient Provider Experience with Diabetes Technology Use on General Medicine Wards: Continuous Subcutaneous Insulin Infusion (CSII) and Continuous Glucose Monitors (CGM)
15. 1253-P: Markers of Beta-Cell Death and Insulin Secretion in Ketosis-Prone Diabetes (KPDM)
16. 733-P: A Randomized Controlled Trial Comparing Insulin Degludec U100 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients with Type 2 Diabetes: Degludec Hospital Trial
17. 1159-P: One-Hour Glucose during Oral Glucose Tolerance Test Predicts Hyperglycemia Relapse in Black Obese Patients with Hyperglycemic Crises
18. 613-P: Performance Evaluation of Dexcom G6 Continuous Glucose Monitoring and Capillary Blood Glucose after Hospital Discharge in Patients with Diabetes
19. 1075-P: Acute and Chronic Glucose Control in Critically Ill Patients with Diabetes: Impact of Prior Insulin Treatment
20. 609-P: Comparison of Dexcom G6 Continuous Glucose Monitoring Performance between Abdomen and Upper Arm Placement in Hospitalized Patients with Diabetes
21. 619-P: Comparison of Dexcom G6 Continuous Glucose Monitoring and Point-of-Care Blood Glucose Testing in Hospitalized Patients with Diabetes
22. 963-P: A Randomized Controlled Trial Comparing Liraglutide vs. Glargine Insulin for the Management of Patients with Type 2 Diabetes after Hospital Discharge
23. 996-P: A Randomized Study to Evaluate the Efficacy of Insulclock Pen Device in Insulin-Treated Patients with Uncontrolled Type 2 Diabetes
24. 1038-P: Insulin Glargine 300 U/ml (Gla-300) vs. First-Generation Standard-of-Care Basal Insulin Analogs (SOC-BI) in Insulin-Naïve Patients with Type 2 Diabetes (T2D): Impact of Renal Function on the Outcomes of the Randomized Pragmatic Real-Life Achieve Control S
25. 1168-P: Effectiveness of a Comprehensive Diabetes Program for Patients with Poorly Controlled Diabetes in an Academic Health Care System: The Emory Diabetes Management Program
26. 1041-P: Randomized Controlled Trial on the Efficacy of Supplemental Rapid-Acting Insulin during Basal-Bolus Regimen in Non-ICU Patients with Type 2 Diabetes
27. 1022-P: Efficacy of Sliding Scale Insulin for Inpatient Glycemic Control in a Multinational Propensity-Matched Cohort Study
28. 1593-P: Real-World Inpatient Use of Oral Antidiabetes Drugs: A Multicenter, Retrospective, Hospital-Based Cohort Study
29. 849-P: Accuracy and Precision of Continuous Glucose Monitoring (CGM) in Hospitalized Patients Undergoing Radiology Procedures
30. 1512-P: Severe Hypoglycemia and Hyperglycemia among U.S. Adults with Diabetes and ESRD on Dialysis, 2010-2015
31. 1669-P: Immune Checkpoint Inhibitor Induced Diabetes and Diabetic Ketoacidosis
32. 136-LB: Efficacy and Safety of Sotagliflozin (SOTA) in Patients with Type 2 Diabetes (T2D) and Moderate Renal Impairment
33. 135-LB: Efficacy and Safety of Sotagliflozin (SOTA) in Patients with Type 2 Diabetes (T2D) and Severe Renal Impairment
34. 113-LB: Home Diabetes Regimen and Admission HbA1c as Predictors of Hospital Glycemic Control: A Pooled Analysis of Inpatient Clinical Trials
35. 2297-PUB: The Shape of Glucose Response Curve during Oral Glucose Tolerance Tests (OGTT) and Long-Term Near-Normoglycemia Remission in African Americans Presenting with Hyperglycemic Crises
36. 792-P: Understanding Barriers to Diabetic Foot Care in an Urban Low-Income Hospital: A Focus Group Qualitative Assessment
37. High Prevalence of Primary Aldosteronism in Diabetic Patients with Resistant Hypertension: 982-P
38. Ketosis-Prone Type 2 Diabetes Mellitus: 968-P
39. Determinants of Progression of Albuminuria in African-American Patients with Type 2 Diabetes: 754-P
40. Underlying Mechanisms in the Pathogenesis of Free Fatty Acid-Induced Hypertension in Obese African-Americans: 699-P
41. The Effects of Rosiglitazone on Free Fatty Acid-Induced Hypertension in Obese Subjects with Type 2 Diabetes: 283-OR
42. Proinflammatory Cytokines, Markers of Cardiovascular Risks, Oxidative Stress, and Lipid Peroxidation in Patients With Hyperglycemic Crises
43. 1246-P: Reducing Hypoglycemia in the Noncritical Care Setting Using CGM Devices: The Glucose Telemetry System
44. 716-P: Addressing Barriers to Diabetes Education and Care in Low Socioeconomic Latinos in Georgia
45. 1913-P: Differences in Glucose Absorption in African American (AA) Patients Presenting with DKA and Severe Hyperglycemia (SH)
46. 1099-P: Sliding Scale Insulin Use in Noncritical Care Settings: Who Can Slide?
47. 1007-P: Incretin Therapy with DPP-4-I and GLP1-RA for the Hospital Management of Elderly Adults with Type 2 Diabetes
48. 1245-P: The Association of Glucose Variability during the Last Day of Hospitalization and 30-Day Readmission in Adults with Diabetes
49. 132-LB: A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients with Type 2 Diabetes: Glargine U300 Hospital Trial
50. Diabetic Ketoacidosis in Obese African-Americans
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.